Product Images Ondansetron

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 3 images provide visual information about the product associated with Ondansetron NDC 16714-200 by Northstar Rx Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 4 mg Blister Carton (3 x 10 Unit-dose) - ondansetronod fig1

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 4 mg Blister Carton (3 x 10 Unit-dose) - ondansetronod fig1

NDC 16714-200-30 is a medication containing Ondansetron Orally Disintegrating Tablets, USP. It comes in a pack of 30 tablets (3 blister cards each containing 10 tablets). The medication is intended for the treatment of nausea and vomiting after chemotherapy, radiation therapy, and surgery. Dosage instructions are not provided. Copyright 2005 Nrastar Hetcar Hotings Inc.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 8 mg Blister Carton (3 x 10 Unit-dose) - ondansetronod fig2

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 8 mg Blister Carton (3 x 10 Unit-dose) - ondansetronod fig2

This is a description for Ondansetron Orally Disintegrating Tablets, USP used to prevent nausea. The tablets are packaged into 3 blister cards, each containing 10 tablets. The medication contains 8mg Ondansetron USP, and each tablet has 37mg of shayan. The pack also contains basic instructions for usage, including dosage recommendations and warnings for storage and dispensing. The manufacturer is Norstar Healthcare Holdings, and the pack is labelled with NDC 16714-201-30.*

Chemical Structure - ondansetronod str

Chemical Structure - ondansetronod str

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.